[Ip-health] Parallel trade “considerable risk” to patient safety, says EC

munoz@southcentre.org munoz@southcentre.org
Mon Jan 21 08:58:03 2008


This is a multipart message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
The European Commission is to prioritise and speed up moves to deal with
the issue of counterfeit drugs in parallel trade and will launch a
legislative initiative on the issue after the summer break

http://www.pharmatimes.com/WorldNews/article.aspx?id=12674